van Es Charles 4
4 · Vita Coco Company, Inc. · Filed May 4, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) CCO Charles van Es Sells 2,000 Shares
What Happened
Charles van Es, Chief Commercial Officer of Vita Coco Company, sold 2,000 shares of common stock in an open-market transaction on May 1, 2026 at $66.87 per share, for total proceeds of $133,740. The filing indicates the sale was executed pursuant to a Rule 10b5-1 trading plan (routine, pre-arranged sale).
Key Details
- Transaction date and price: May 1, 2026 — 2,000 shares sold at $66.87 per share (total $133,740). Transaction code: S (sale).
- Method: Open market sale reported; footnote F1 confirms the sale was under a Rule 10b5-1 plan.
- Shares owned after transaction: Not disclosed in this Form 4.
- Filing timeliness: Form filed May 4, 2026 (appears to be timely).
- Related footnotes: Filing includes several footnotes about option vesting schedules (F2–F8). Notably, F5 states that performance conditions were met resulting in vesting of options covering 14,025 shares on Feb 20, 2026.
Context
Sales under a 10b5-1 plan are typically pre-planned and do not necessarily indicate new company-specific information. This report documents a routine insider sale rather than a purchase; retail investors often view purchases as a stronger signal of insider confidence.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-05-01$66.87/sh−2,000$133,740→ 75,691 total
- 53,750
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2030-02-10→ Common Stock (53,750 underlying) - 27,300
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying) - 58,043
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying) - 42,980
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying) - 14,025
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying) - 14,205
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (8)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option is fully vested and currently exercisable.
- [F3]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F4]The stock option vests in three equal annual installments beginning on August 15, 2025.
- [F5]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
- [F6]The stock options vest in four annual equal installments beginning on March 10, 2024.
- [F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F8]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.